Eruption maculo-papuleuse

  • cabozantinib (Cabometyx®)
  • pazopanib (Votrient®)
  • regorafenib (Stivarga®)
  • sunitinib (Sutent®)
  • afatinib (Giotrif®)
  • erlotinib (Tarceva®)
  • gefitinib (Iressa®)
  • osimertinib (Tagrisso®)
  • panitumumab (Vectibix®)
  • alectinib (Alecensa®)
  • ceritinib (Zykadia®)
  • lorlatinib (Lorviqua®)
  • lapatinib (Tyverb®)
  • trastuzumab (Herceptin®)
  • dabrafenib (Tafinlar®)
  • encorafenib (Braftovi®)
  • vemurafenib (Zelboraf®)
  • niraparib (Zejula®)
  • olaparib (Lynparza®)
  • rucaparib (Rubraca®)
  • binimetinib (Mektovi®)
  • cobimetinib (Cotellic®)
  • trametinib (Mekinist®)
  • evérolimus (Afinitor®)
  • temsirolimus (Torisel®)
  • vismodegib (Erivedge®)